NCT06873945: A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- State
- Under way
- Phase
- Phase 3
- People
- 674 planned
- Started
- 1 Apr 2025
- Primary completion
- 19 Mar 2028
- Arms
- Ritlecitinib 100 mg
- Results
- None posted
- 13 Mar 2025: Trial registered
- 1 Apr 2025: Trial started